Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men - Role of the metabolic syndrome

Thrombosis and Haemostasis

Volumn 76, Issue 1, 1996, Pages 69-73

  Cigolini, M ^a,b   Targher, G ^a   Agostino, G ^a   Tonoli, M ^a   Muggeo, M ^a   De Sandre, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Ospedale Borgo Roma   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 7; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INSULIN BLOOD LEVEL; MALE; METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030015663     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650524     Document Type: Article

References (34)

1. Asplund-Carlson A, Hamsten A, Wiman B, Carlson LA. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia 1993; 36: 817-25.
2. Bruckert E, Ankri A, Jung M, Turpin G, De Gennes JL. Mild liver abnormalities associated with elevated plasma factor VII and protein C in hypertriglyceridaemic patients. Eur J Med 1993; 8: 461-5.
3. Bruckert E, Ankri A, Giral P, Turpin G. Relation between plasminogen activator inhibitor-1 and hepatic enzyme concentrations in hyperlipidemic patients. Thromb Haemost 1994; 72: 434-7.
4. Cigolini M, Targher G, Seidell JC, Schiavon R, Manara F, Zenti MG, Mattioli C, De Sandre G. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose-tissue fatty acids in healthy men. Atherosclerosis 1994; 106: 139-46.
5. Cigolini M, Targher G, De Sandre G, Muggeo M, Seidell JC. Plasma fibrinogen in relation to serum insulin, smoking habits and adipose-tissue fatty acids in healthy men. Eur J Clin Invest 1994; 24: 126-30.
6. Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-yr-old healthy men and women. Int J Obes 1995; 19: 92-6.
7. Gossink BB, Lemon SK, Scheible W, Leopold GR. Accuracy of ultrasonography in diagnosis of hepatocellular disease. Am J Roentgenol 1979; 133: 19-23.
8. Dawson S, Henney A. The status of PAI-1 as a risk for arterial and thrombotic disease: a review. Atherosclerosis 1992; 95: 105-17.
9. Hamsten A. The hemostatic system and coronary heart disease. Thromb Res 1993; 70: 1-38.
10. Hamsten A, Wiman B, De Faire U, Blombäck M. Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-63.
11. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
12. Clain DJ, Lefkowitch JH. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 1987; 16: 239-52.
13. Braillon A, Capron JP. Foie et obésité. Gastroenterol Clin Biol 1983; 7: 627-34.
14. Seidell JC, Cigolini M, Deslypere JP, Charzewska J, Ellsinger BM, Cruz A. Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men. The European Fat Distribution Study. Atherosclerosis 1991; 86: 251-60.
15. Seidell JC, Cigolini M, Deslypere JP, Charzewska J, Ellsinger BM, Cruz A. Body fat distribution in relation to physical activity and smoking habits in 38-year-old European men. The European Fat Distribution Study. Am J Epidemiol 1991; 133: 257-65.
16. Reaven GM. Banting lecture: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
17. De Fronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
18. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-62.
19. Eliasson M, Asplund K, Evrin PE, Lindahl B, Lundblad D. Hyperinsulinaemia predicts low tissue plasminogen activator activity in a healthy population. The Northern Sweden MONICA Study. Metabolism 1994; 43: 1579-86.
20. Juhan-Vague I, Thompson SG, Jespersen J, on behalf of the ECAT Angina Pectoris Study Group. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb 1993; 13: 1865-73
21. Mykkänen L, Rönnemaa T, Marniemi J, Haffner SM, Bergmann R, Laakso M. Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1994; 14: 1264-71.
22. Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987; 9: 263-68.
23. Raccah D, Alessi MC, Scelles V, Menard C, Julian-Vague I, Vague P. Plasminogen activator inhibitor activity in various types of endogenous hypertriglyceridemia. Fibrinolysis 1993; 7: 171-76.
24. Miller GJ, Martin JC, Mitropoulos KA, Reeves RL, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridemia, irrespective of dietary fat composition. Atherosclerosis 1991; 86: 163-71.
25. Mitropoulos KA, Miller GJ, Reeves RL, Wilkes HC, Cruickshank JK. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. Atherosclerosis 1989; 76: 203-8.
26. Folsom AR, Wu RR, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
27. Moor E, Hamsten A, Karpe F, Båvenholm P, Blombäck M, Silveira A. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction. Thromb Haemost 1994; 71: 707-12.
28. Mitropoulos KA, Esnouf MP. The autoactivation of factor XII in the presence of long-chain saturated fatty acids: a comparison with the potency of sulphatides and dextran sulphate. Thromb Haemost 1991; 66: 446-52.
29. Mitropoulos KA, Martin JC, Reeves BEA, Esnouf MP. The activation of the contact phase of coagulation by physiological surfaces in plasma: the effect of large negatively charged liposomal vescicles. Blood 1989; 73: 1523-33.
30. Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10: 1067-73.
31. Mussoni L, Mannucci L, Sirtori M, Camera M, Maderna P, Sironi L, Tremoli E. Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb 1992; 12: 19-25.
32. Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor-1 by the human hepatocellular cell line Hep G2. Thromb Haemost 1988; 60: 491-94.
33. Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type I by insulin and insulin-like growth factor type 1: implications for vascular disease in hyperinsulinemic states. Proc Natl Acad Sci USA 1991; 88: 9959-63.
34. Tran-Than C, Fasel-Felley J, Pralong G, Hofstetter JR, Bachmann F, Kruithof EKO. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemost 1989; 62: 651-53